Depression in Heart Failure: Psychosomatic Approach

Depression is a common condition in heart failure (HF) and is considered a risk factor for cardiovascular disease. Depression disorder in patients with heart disease paradigmatically defines a psychosomatic-somatopsychic challenge to any health delivery. However, despite the devastating effects of d...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rudi Putranto, Hamzah Shatri, Ika Prasetya Wijaya, Edward Faisal
Formato:	article
Lenguaje:	ID
Publicado:	Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital 2021
Materias:	depression diagnosis heart failure psychosomatic Internal medicine RC31-1245
Acceso en línea:	http://dx.doi.org/10.7454/jpdi.v8i3.182 https://doaj.org/article/133d01fef2a84a15ab17e8de71a2da8c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:133d01fef2a84a15ab17e8de71a2da8c
record_format	dspace
spelling	oai:doaj.org-article:133d01fef2a84a15ab17e8de71a2da8c2021-11-17T14:09:41ZDepression in Heart Failure: Psychosomatic Approachhttp://dx.doi.org/10.7454/jpdi.v8i3.1822406-89692549-0621https://doaj.org/article/133d01fef2a84a15ab17e8de71a2da8c2021-09-01T00:00:00Zhttp://jurnalpenyakitdalam.ui.ac.id/index.php/jpdi/article/view/182/281https://doaj.org/toc/2406-8969https://doaj.org/toc/2549-0621Depression is a common condition in heart failure (HF) and is considered a risk factor for cardiovascular disease. Depression disorder in patients with heart disease paradigmatically defines a psychosomatic-somatopsychic challenge to any health delivery. However, despite the devastating effects of depression, it is often underdiagnosed and receives little attention in heart failure patients. This review provides an extensive overview of HF regarding epidemiology, disease pathophysiology, diagnosis, and management from the latest literature. Based on the literature review, the prevalence of depression in heart failure in Indonesian patients was 5.3-42%. Psychological stress experienced by people suffering from depression can cause dysregulation in the sympathetic nervous system and hypothalamic–pituitary–adrenal (HPA) axis. This mechanism, in turn, has some deleterious downstream effects, including the development of hypertension, left ventricular hypertrophy, coronary vasoconstriction, endothelial dysfunction, platelet activation, and the production of pro-inflammatory cytokines. The Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5), published by the American Psychiatric Association, is used to diagnose depression in patients with HF. Meanwhile, the Patient Health Questionnaire (PHQ)-2 and PHQ-9 are commonly used as screening tools for depression in patients with HF. The Biopsychosocial-spiritual model as a psychosomatic approach have might reduce or prevent depression and thus improve quality of life and other outcomes. Evidence reveals that both psychotherapeutic treatment (e.g., cognitive-behavioral therapy) and pharmacologic treatment (e.g., use of the selective serotonin reuptake inhibitor sertraline) are safe and effective in managing depression in patients with cardiovascular disease. In conclusion, the review of articles in this paper shows that there is a high prevalence of depression in heart failure, but it is often not recognized by doctors, there is a relationship between psychosomatic, and heart failure, non-pharmacological interventions such as psychotherapy and pharmacological therapy have benefits. Future research is needed to create evidence-based evaluations and treatment algorithms tailored to the specific needs of the target population.Rudi PutrantoHamzah ShatriIka Prasetya WijayaEdward FaisalDepartment of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospitalarticledepressiondiagnosisheart failurepsychosomaticInternal medicineRC31-1245IDJurnal Penyakit Dalam Indonesia, Vol 8, Iss 3, Pp 154-160 (2021)
institution	DOAJ
collection	DOAJ
language	ID
topic	depression diagnosis heart failure psychosomatic Internal medicine RC31-1245
spellingShingle	depression diagnosis heart failure psychosomatic Internal medicine RC31-1245 Rudi Putranto Hamzah Shatri Ika Prasetya Wijaya Edward Faisal Depression in Heart Failure: Psychosomatic Approach
description	Depression is a common condition in heart failure (HF) and is considered a risk factor for cardiovascular disease. Depression disorder in patients with heart disease paradigmatically defines a psychosomatic-somatopsychic challenge to any health delivery. However, despite the devastating effects of depression, it is often underdiagnosed and receives little attention in heart failure patients. This review provides an extensive overview of HF regarding epidemiology, disease pathophysiology, diagnosis, and management from the latest literature. Based on the literature review, the prevalence of depression in heart failure in Indonesian patients was 5.3-42%. Psychological stress experienced by people suffering from depression can cause dysregulation in the sympathetic nervous system and hypothalamic–pituitary–adrenal (HPA) axis. This mechanism, in turn, has some deleterious downstream effects, including the development of hypertension, left ventricular hypertrophy, coronary vasoconstriction, endothelial dysfunction, platelet activation, and the production of pro-inflammatory cytokines. The Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5), published by the American Psychiatric Association, is used to diagnose depression in patients with HF. Meanwhile, the Patient Health Questionnaire (PHQ)-2 and PHQ-9 are commonly used as screening tools for depression in patients with HF. The Biopsychosocial-spiritual model as a psychosomatic approach have might reduce or prevent depression and thus improve quality of life and other outcomes. Evidence reveals that both psychotherapeutic treatment (e.g., cognitive-behavioral therapy) and pharmacologic treatment (e.g., use of the selective serotonin reuptake inhibitor sertraline) are safe and effective in managing depression in patients with cardiovascular disease. In conclusion, the review of articles in this paper shows that there is a high prevalence of depression in heart failure, but it is often not recognized by doctors, there is a relationship between psychosomatic, and heart failure, non-pharmacological interventions such as psychotherapy and pharmacological therapy have benefits. Future research is needed to create evidence-based evaluations and treatment algorithms tailored to the specific needs of the target population.
format	article
author	Rudi Putranto Hamzah Shatri Ika Prasetya Wijaya Edward Faisal
author_facet	Rudi Putranto Hamzah Shatri Ika Prasetya Wijaya Edward Faisal
author_sort	Rudi Putranto
title	Depression in Heart Failure: Psychosomatic Approach
title_short	Depression in Heart Failure: Psychosomatic Approach
title_full	Depression in Heart Failure: Psychosomatic Approach
title_fullStr	Depression in Heart Failure: Psychosomatic Approach
title_full_unstemmed	Depression in Heart Failure: Psychosomatic Approach
title_sort	depression in heart failure: psychosomatic approach
publisher	Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital
publishDate	2021
url	http://dx.doi.org/10.7454/jpdi.v8i3.182 https://doaj.org/article/133d01fef2a84a15ab17e8de71a2da8c
work_keys_str_mv	AT rudiputranto depressioninheartfailurepsychosomaticapproach AT hamzahshatri depressioninheartfailurepsychosomaticapproach AT ikaprasetyawijaya depressioninheartfailurepsychosomaticapproach AT edwardfaisal depressioninheartfailurepsychosomaticapproach
_version_	1718425463871766528

Depression in Heart Failure: Psychosomatic Approach

Ejemplares similares